Neuphoria Therapeutics Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Jun 2022 | — | — | $23.2M |
| Jun 2023 | $6.6M | $28.6M | $12.1M |
| Sep 2023 | — | — | $8.1M |
| Dec 2023 | — | — | $10.2M |
| Mar 2024 | — | — | $8.4M |
| Jun 2024 | $10.2M | $27.6M | $12.6M |
| Sep 2024 | $5.8M | $22.9M | $8.1M |
| Dec 2024 | $4.4M | $18.2M | $4.3M |
| Mar 2025 | $4.7M | $30.7M | $17.0M |
| Jun 2025 | $9.6M | $28.6M | $14.2M |
| Sep 2025 | $14.8M | $27.3M | $13.6M |
| Dec 2025 | $6.9M | $36.6M | $22.2M |
| Mar 2026 | $5.4M | $34.8M | $19.4M |